Bioactive natural products from novel microbial sources.

Area of Science:

• Microbiology
• Natural Product Chemistry
• Drug Discovery

Background:

• The urgent threat of antibiotic resistance necessitates the discovery of new antimicrobial compounds.
• Despite their potential, only a limited number of bacterial genera have been explored for natural product mining.
• Genome sequencing reveals that natural product biosynthesis is a widespread capability among bacteria.

Purpose of the Study:

• To highlight under-explored bacterial groups as promising sources for novel natural products.
• To emphasize the potential of microbial natural products in addressing antibiotic resistance.
• To advocate for the exploitation of diverse bacterial communities for therapeutic discoveries.

Main Methods:

• Review of existing literature on bacterial natural product biosynthesis.
• Identification of key bacterial groups (e.g., anaerobes, pathogens, symbionts) with potential for novel compound production.
• Discussion of advances in natural product research methodologies.

Main Results:

• Genome data indicates a vast, unexploited reservoir of natural product-producing bacteria.
• Bacteria from the human microbiome represent a significant, untapped resource for antibiotic discovery.
• Specific examples of promising bacterial sources including human, insect, and nematode symbionts are presented.

Conclusions:

• Diverse bacterial communities, including those in the human microbiome, are critical untapped resources for novel natural products.
• Targeted exploitation of these producer strains, coupled with advanced research methods, can drive the discovery of new microbial therapeutics.
• This approach holds the potential to initiate a new era in the development of treatments for infectious diseases.